Motus GI (NASDAQ:MOTS) Downgraded by LADENBURG THALM/SH SH

Motus GI (NASDAQ:MOTS – Get Rating) was downgraded by LADENBURG THALM/SH SH to a “neutral” rating in a report issued on Wednesday, The Fly reports.

A number of other equities analysts have also recently issued reports on the company. HC Wainwright cut their price target on Motus GI from $11.00 to $10.00 and set a “buy” rating on the stock in a report on Tuesday, November 15th. Piper Sandler cut their target price on Motus GI from $10.00 to $6.00 and set an “overweight” rating on the stock in a report on Monday, November 14th. Oppenheimer cut their target price on Motus GI to $5.00 in a report on Thursday, November 17th. Finally, Alliance Global Partners cut their target price on Motus GI from $12.00 to $2.25 in a report on Tuesday, November 15th.

Motus GI Stock Performance

Shares of MOTS stock opened at $1.02 on Wednesday. The stock has a market capitalization of $3.06 million, a PE ratio of -0.14 and a beta of 1.83. Motus GI has a one year low of $0.68 and a one year high of $13.00. The business’s 50 day simple moving average is $1.11 and its 200 day simple moving average is $2.43. The company has a debt-to-equity ratio of 11.98, a current ratio of 2.83 and a quick ratio of 2.65.

Motus GI (NASDAQ:MOTS – Get Rating) last posted its quarterly earnings results on Monday, November 14th. The company reported ($1.69) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.87) by $0.18. The firm had revenue of $0.28 million for the quarter, compared to analysts’ expectations of $0.33 million. Motus GI had a negative return on equity of 343.21% and a negative net margin of 3,390.55%. As a group, research analysts forecast that Motus GI will post -6.18 earnings per share for the current year.

Hedge Funds Weigh In On Motus GI

A number of large investors have recently modified their holdings of the company. Renaissance Technologies LLC raised its position in Motus GI by 73.5% in the 2nd quarter. Renaissance Technologies LLC now owns 127,500 shares of the company’s stock valued at $36,000 after buying an additional 54,000 shares during the last quarter. Millennium Management LLC raised its position in Motus GI by 237.7% in the 2nd quarter. Millennium Management LLC now owns 114,987 shares of the company’s stock valued at $32,000 after buying an additional 80,938 shares during the last quarter. Finally, Virtu Financial LLC purchased a new stake in Motus GI in the 2nd quarter valued at $56,000. 6.40% of the stock is currently owned by institutional investors.

About Motus GI

(Get Rating)

Motus GI Holdings, Inc is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. It engages in the development and commercialization of the Pure-Vu System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.